AssetMark’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.6K Hold
241
– – ﹤0.01% 2969
2026
Q2
$2.27K Hold
241
– – ﹤0.01% 2932
2026
Q1
$1.96K Hold
241
– – ﹤0.01% 2864
2025
Q4
$1.62K Sell
241
-1
-0.4% -$8 ﹤0.01% 2819
2025
Q3
$2.1K Buy
+242
New +$1.88K ﹤0.01% 2618
2016
Q1
– Sell
-1
Closed – – 1343
2015
Q4
$0 Buy
+1
New +$154 ﹤0.01% 1453

Other funds holding NVAX

AssetMark's NVAX Position: Q3 2026 in Review

AssetMark held its Novavax (NVAX) position steady in Q3 2026 at 241 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

AssetMark first reported a position in NVAX in Q4 2015 and has held it in 6 quarters since. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • AssetMark held 241 shares of Novavax worth $2.6K as of Q3 2026.
  • AssetMark left its Novavax share count unchanged in Q3 2026.
  • Novavax made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2969 holding.
  • AssetMark first reported a position in Novavax in Q4 2015 and has held it in 6 quarters since.
  • 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.